• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL-4 诱导的 BCR 信号转导的替代途径需要 Lyn 酪氨酸激酶。

The Alternate Pathway for BCR Signaling Induced by IL-4 Requires Lyn Tyrosine Kinase.

机构信息

Center for Immunobiology and Department of Investigative Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, 300 Portage Street, Kalamazoo, MI 49007, United States.

Center for Immunobiology and Department of Investigative Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, 300 Portage Street, Kalamazoo, MI 49007, United States.

出版信息

J Mol Biol. 2021 Jan 8;433(1):166667. doi: 10.1016/j.jmb.2020.10.002. Epub 2020 Oct 13.

DOI:10.1016/j.jmb.2020.10.002
PMID:33058880
Abstract

BCR signaling triggers a cascade of intracellular mediators that eventuates in transcription factor activation. Signaling is proximally mediated by Src family tyrosine kinases, the most abundant being Lyn. Key mediators are grouped together as the signalosome, and failure of any single member of this group leads to failure of signaling via this classical pathway. Recent work has revealed an alternate pathway for BCR signaling, in which signalosome elements are bypassed for downstream events such as ERK and PKCδ phosphorylation. This pathway is created by B cell treatment with IL-4 prior to BCR triggering. After IL-4 treatment, the alternate pathway for pERK operates in parallel with the classical pathway for pERK, whereas PKCδ phosphorylation is specific to the alternate pathway. Remarkably, Lyn is not required for B cell activation via the classical pathway; however, Lyn is indispensable and irreplaceable for B cell activation via the alternate pathway. Thus, Lyn operates at a branch point that determines the nature of the B cell response to BCR activation. The mechanism underlying the absolute dependence of alternate pathway signaling on Lyn is unknown. Here, our current understanding of receptor crosstalk between IL-4R and BCR is summarized along with several possible mechanisms for the role of Lyn in alternate pathway signaling. Further dissection of alternate pathway signaling and the role of Lyn is likely to provide important information relating to normal B cell responses, malignant B cell expansion, and generic principles relating to receptor interactions and crosstalk.

摘要

BCR 信号触发细胞内介质的级联反应,最终导致转录因子激活。信号的近程介导由 Src 家族酪氨酸激酶完成,其中最丰富的是 Lyn。关键介质被归为信号体,该组中任何单个成员的失败都会导致通过该经典途径的信号传导失败。最近的工作揭示了 BCR 信号的另一种途径,其中信号体元件被绕过,用于下游事件,如 ERK 和 PKCδ 的磷酸化。该途径是通过 B 细胞在 BCR 触发前用 IL-4 处理而创建的。在 IL-4 处理后,替代途径的 pERK 与经典途径的 pERK 并行运行,而 PKCδ 的磷酸化则是替代途径特有的。值得注意的是,Lyn 对于经典途径中的 B 细胞激活不是必需的;然而,Lyn 对于替代途径中的 B 细胞激活是不可或缺且不可替代的。因此,Lyn 在分支点上运作,决定了 B 细胞对 BCR 激活的反应性质。替代途径信号对 Lyn 的绝对依赖性的机制尚不清楚。在这里,我们总结了目前对 IL-4R 和 BCR 之间受体串扰的理解,以及 Lyn 在替代途径信号中的作用的几种可能机制。进一步剖析替代途径信号和 Lyn 的作用可能为正常 B 细胞反应、恶性 B 细胞扩增以及与受体相互作用和串扰相关的一般原则提供重要信息。

相似文献

1
The Alternate Pathway for BCR Signaling Induced by IL-4 Requires Lyn Tyrosine Kinase.IL-4 诱导的 BCR 信号转导的替代途径需要 Lyn 酪氨酸激酶。
J Mol Biol. 2021 Jan 8;433(1):166667. doi: 10.1016/j.jmb.2020.10.002. Epub 2020 Oct 13.
2
A novel Lyn-protein kinase Cδ/ε-protein kinase D axis is activated in B cells by signalosome-independent alternate pathway BCR signaling.一种新型 Lyn 蛋白激酶 Cδ/ε-蛋白激酶 D 轴在 B 细胞中被信号小体非依赖性替代途径 BCR 信号激活。
Eur J Immunol. 2013 Jun;43(6):1643-50. doi: 10.1002/eji.201242830. Epub 2013 Apr 12.
3
TLR Engagement Induces an Alternate Pathway for BCR Signaling that Results in PKCδ Phosphorylation.TLR 衔接诱导 BCR 信号的替代途径,导致 PKCδ 的磷酸化。
J Immunol. 2024 Jun 1;212(11):1639-1646. doi: 10.4049/jimmunol.2300784.
4
Signal Integration by Translocation and Phosphorylation of PKCδ in the B Cell Alternate Pathway.PKCδ 通过易位和磷酸化在 B 细胞替代途径中进行信号整合。
J Immunol. 2021 Nov 1;207(9):2288-2296. doi: 10.4049/jimmunol.2100295. Epub 2021 Sep 29.
5
Cutting Edge: B cell receptor (BCR) cross-talk: the IL-4-induced alternate pathway for BCR signaling operates in parallel with the classical pathway, is sensitive to Rottlerin, and depends on Lyn.前沿:B细胞受体(BCR)串扰:白细胞介素4诱导的BCR信号转导替代途径与经典途径并行运作,对rottlerin敏感,且依赖Lyn。
J Immunol. 2007 Apr 15;178(8):4726-30. doi: 10.4049/jimmunol.178.8.4726.
6
CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.CD19通过调节Src家族蛋白酪氨酸激酶的激活来增强B淋巴细胞信号转导。
J Immunol. 1999 Jun 15;162(12):7088-94.
7
Functional analysis of Csk in signal transduction through the B-cell antigen receptor.Csk在通过B细胞抗原受体进行信号转导中的功能分析。
Mol Cell Biol. 1994 Nov;14(11):7306-13. doi: 10.1128/mcb.14.11.7306-7313.1994.
8
A systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model.系统毒理学方法鉴定 Lyn 作为一个关键的信号磷酸化蛋白,在 B 淋巴细胞模型中受汞调节。
Toxicol Appl Pharmacol. 2014 Apr 1;276(1):47-54. doi: 10.1016/j.taap.2014.01.002. Epub 2014 Jan 14.
9
B cell receptor crosstalk: B cells express osteopontin through the combined action of the alternate and classical BCR signaling pathways.B细胞受体串扰:B细胞通过替代和经典BCR信号通路的联合作用表达骨桥蛋白。
Mol Immunol. 2009 Feb;46(4):587-91. doi: 10.1016/j.molimm.2008.07.029. Epub 2008 Oct 25.
10
B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.B细胞受体(BCR)串扰:CD40参与为BCR信号传导创造了一条替代途径,该途径可激活IκB激酶/IκBα/NF-κB,而无需PI3K和磷脂酶Cγ。
J Immunol. 2005 May 15;174(10):6062-70. doi: 10.4049/jimmunol.174.10.6062.

引用本文的文献

1
B-Cell Receptor Signaling and Beyond: The Role of Igα (CD79a)/Igβ (CD79b) in Normal and Malignant B Cells.B 细胞受体信号转导及其他:Igα(CD79a)/Igβ(CD79b)在正常和恶性 B 细胞中的作用。
Int J Mol Sci. 2023 Dec 19;25(1):10. doi: 10.3390/ijms25010010.
2
Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia.评估人类白细胞抗原类型和细胞因子类型反应对目前用于治疗慢性淋巴细胞白血病的靶向治疗后结局的影响。
J Clin Med. 2023 Apr 6;12(7):2731. doi: 10.3390/jcm12072731.
3
Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia.
共济失调毛细血管扩张症中的代谢应激与线粒体功能障碍
Antioxidants (Basel). 2022 Mar 28;11(4):653. doi: 10.3390/antiox11040653.